# Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other Diseases

> **NCT03389399** · — · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 18 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03389399
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-22
- **Primary completion:** 2021-10-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-03-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03389399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03389399, "Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other Diseases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03389399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*